0
     

Report Added
Report already added
HMO Market by Type (2’ Fl, 3’ Fl, 3’ Sl, 6’ Sl), Application (Infant Formula, Functional Food & Beverages, Food Supplement), Concentration (Acidic, Neutral) & Region (North America, Europe, APAC, South America, RoW) - Global Forecast to 2027

HMO Market by Type (2’ Fl, 3’ Fl, 3’ Sl, 6’ Sl), Application (Infant Formula, Functional Food & Beverages, Food Supplement), Concentration (Acidic, Neutral) & Region (North America, Europe, APAC, South America, RoW) - Global Forecast to 2027

The global market for HMO market is estimated to be valued at USD 199 million in 2022. It is projected to reach USD 556 million by 2027, recording a CAGR of 22.7% during the forecast period. Human milk oligosaccharides (HMOs) are part of the functional ingredients of breast milk. They are the third most abundant component of milk after lactose and lipids. HMOs act as prebiotics; they support beneficial bacteria growth and have anti-pathogenic effects. Recent studies show that HMOs can boost infant health and reduce disease risk. HMOs are the main nutrients that benefit infants’ growth and are abundantly present in human milk. Currently, HMOs have been synthesized artificially in infant milk formulations to benefit infants who cannot be fed with breast milk, support their growth, and provide them with protection against diseases.

“Asia Pacific is projected to witness the growth of 23.2% during the forecast period.”

The Asia Pacific region accounts USD 92.6 Million of the market size in global market for HMO. The region is expected to grow at the highest CAGR during the forecast period, retaining its dominance as the leading market for HMOs. Asia Pacific is the most densely populated region consisting of countries like China, India, Japan, Australia & New Zealand and Others. It is also one of the key markets for HMOs. China is a dominant market in the region, as it is one of the largest consumers of infant formulas in the world. Hence, any market fluctuation in China is expected to significantly affect the global infant formulas market, which will, in turn, affect the HMO market.

China is expected to be the largest market for human milk oligosaccharides (HMO) in 2022. The country has witnessed high adoption of infant formula crafted with premium ingredients, including HMOs, mainly due to the increasing income level, modernization, and middle-class population. The government in China has started easing its stand on the one-child policy and is allowing couples to have two children. This is expected to increase the number of newborn infants, which will, in turn, boost the demand for HMOs.

“The type 2’ FL is gaining rapid popularity in the HMO market across the globe.”

HMOs are known to have Bifidus, a beneficial bacteria species also known as Bifidobacterium. 2’FL selectively grows in intestinal Bifidobacterium because of three different bifidobacterial categories, such as B. dentium, Bifidobacterium bifidum, and B. infantis. On account of their numerous health benefits and a wide array of applications, 2’FL-based HMOs have become popular over the past few years. Various government agencies are granting their approval for their industrial and commercial use. For instances; in July 2021, according to Taiwan Food and Drug Administration, Taiwan authorized the usage of 2’FL Human Milk Oligosaccharides (HMO) in infant formula, milk formula for children aged below seven years, food formula for kids aged below seven years, and growing-up formula. The allowed use of this formula is 1.2g/liter. The 2’FL segment is estimated to dominate the market in 2022, as a result of rigorous and ongoing research in the development of 2’FL-based HMOs by key players.

“Extensive R&D activities by infant formula manufacturers.”

In Infant formula is made from industrially modified. It is intended to be used as a substitute for breast milk and is formulated by manufacturers to mimic the nutritional composition of breast milk for the overall growth and development of infants. According to an article published by the National Library of Medicine in June 2019, from the age of 6 months, an infant’s energy and nutrient requirements start to exceed those provided by breast milk.

A lot of research and activities are being conducted by the key market players for developing HMO-based infant formula, baby food etc. for supporting the infant health across the world. Manufacturers involved in the development of infant formulas are constantly engaged in the research and development activities for creating new formulas and ingredients as per the customer requirements. For instance; in January 2019, Nestlé (Switzerland) opened a new R&D center in Ireland. The company made an investment of USD 30.0 million for the same. The center is likely to focus on developing products for infant nutrition. Infant formulas, by providing for the deficiencies, play an important role in the development of infants.

Break-up of Primaries:
By HMO Manufacturers: Managers – 50.0%, Directors - 30.0%, Junior Level Employees – 20.0%
By Designation: Managers – 30.0%, CXOs – 26.0%, and Executives- 44.0%
By Country: India - 55%, US – 20%, UK - 20%, China – 5%

Leading players profiled in this report:
•DSM (Netherlands)
•BASF SE (Germany)
•CHR Hansen Holding A/S (Denmark)
•DUPONT (US)
•Nestle (Switzerland)
•Biosynth Carbosynth (US)
•Inbiose N.V (Belgium)
•Gnubiotics Sciences S.A ( Switzerland)
•Abbott Laboratories (US)
•Royal Friesland Campina N.V (Netherlands)
•Elicityl S.A (France)
•Dextra Laboratories (UK)

Research Coverage:
The report segments the HMO market on the basis of type, end-user, nature, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the HMO, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.

Reasons to buy this report:
•To get a comprehensive overview of the HMO market
•To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them
•To gain insights about the major countries/regions in which the HMO market is flourishing
Table of Contents

1INTRODUCTION23
1.1OBJECTIVES OF THE STUDY23
1.2MARKET DEFINITION23
1.3STUDY SCOPE24
FIGURE 1MARKET SEGMENTATION24
TABLE 1INCLUSIONS AND EXCLUSIONS24
1.4REGIONS COVERED25
1.5PERIODIZATION CONSIDERED25
1.6CURRENCY CONSIDERED26
TABLE 2USD EXCHANGE RATES CONSIDERED, 2017–202126
1.7UNITS CONSIDERED26
1.8STAKEHOLDERS27
1.9INTRODUCTION TO COVID-1927
2RESEARCH METHODOLOGY28
2.1RESEARCH DATA28
FIGURE 2HUMAN MILK OLIGOSACCHARIDES MARKET: RESEARCH DESIGN28
2.1.1SECONDARY DATA29
2.1.1.1Key data from secondary sources29
2.1.2PRIMARY DATA29
2.1.2.1Key data from primary sources30
2.1.2.2Key industry insights30
2.1.2.3Breakdown of primary interviews31
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION31
2.2MARKET SIZE ESTIMATION31
FIGURE 4HUMAN MILK OLIGOSACCHARIDES MARKET SIZE ESTIMATION, BY TYPE (SUPPLY-SIDE)32
FIGURE 5HUMAN MILK OLIGOSACCHARIDES MARKET SIZE ESTIMATION (DEMAND-SIDE)33
2.2.1MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH33
FIGURE 6HUMAN MILK OLIGOSACCHARIDES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH34
2.2.2MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH34
FIGURE 7HUMAN MILK OLIGOSACCHARIDES MARKET SIZE ESTIMATION: TOP-DOWN APPROACH35
2.3DATA TRIANGULATION36
FIGURE 8DATA TRIANGULATION36
2.4ASSUMPTIONS FOR THE STUDY37
2.5RESEARCH LIMITATIONS & ASSOCIATED RISKS38
2.6MARKET SCENARIOS CONSIDERED FOR THE IMPACT OF COVID-1939
2.6.1SCENARIO-BASED MODELLING39
2.7COVID-19 HEALTH ASSESSMENT40
FIGURE 9COVID-19: GLOBAL PROPAGATION40
FIGURE 10COVID-19 PROPAGATION: SELECT COUNTRIES41
2.8COVID-19 ECONOMIC ASSESSMENT42
FIGURE 11REVISED GROSS DOMESTIC PRODUCT FORECASTS FOR SELECT G20 COUNTRIES IN 202042
2.8.1COVID-19 ECONOMIC IMPACT—SCENARIO ASSESSMENT43
FIGURE 12CRITERIA IMPACTING GLOBAL ECONOMY43
FIGURE 13SCENARIOS IN TERMS OF RECOVERY OF GLOBAL ECONOMY44
3EXECUTIVE SUMMARY46
TABLE 3HUMAN MILK OLIGOSACCHARIDES MARKET SNAPSHOT, 2022 VS. 202747
FIGURE 14HUMAN OLIGOSACCHARIDES MARKET, BY TYPE, 2022 VS. 202747
FIGURE 15HUMAN OLIGOSACCHARIDES MARKET, BY APPLICATION, 2022 VS. 202748
FIGURE 16HUMAN OLIGOSACCHARIDES MARKET, BY CONCENTRATION, 2022 VS. 202748
FIGURE 17HUMAN MILK OLIGOSACCHARIDES MARKET: REGIONAL SNAPSHOT49
4PREMIUM INSIGHTS50
4.1ATTRACTIVE OPPORTUNITIES IN THE HUMAN MILK OLIGOSACCHARIDES MARKET50
FIGURE 18HUMAN MILK OLIGOSACCHARIDES IMPART MEMORY ENHANCEMENT, GUT HEALTH MAINTENANCE, AND BRAIN DEVELOPMENT TO INFANTS50
4.2HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION51
FIGURE 19ASIA PACIFIC EXPECTED TO DOMINATE THE HUMAN MILK OLIGOSACCHARIDES MARKET BY 2027 IN TERMS OF VALUE51
FIGURE 20ASIA PACIFIC EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD, BY VOLUME TERMS51
4.3HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE52
FIGURE 212’FL SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST MARKET SIZE DURING THE FORECAST PERIOD BY VALUE TERMS52
FIGURE 22MARKET FOR 2’FL-BASED HMOS EXPECTED TO ACCOUNT FOR THE LARGEST MARKET SIZE BY 2027 IN TERMS OF VOLUME52
4.4HUMAN MILK OLIGOSACCHARIDES MARKET, BY CONCENTRATION53
FIGURE 23NEUTRAL HUMAN MILK OLIGOSACCHARIDES SEGMENT EXPECTED TO ACCOUNT FOR A LARGER SIZE DURING THE FORECAST PERIOD53
4.5HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION53
FIGURE 24DEMAND FOR HMOS IN INFANT FORMULA APPLICATION EXPECTED TO BE THE HIGHEST DURING THE FORECAST PERIOD53
4.6ASIA PACIFIC: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE & KEY COUNTRY54
FIGURE 25CHINA AND 2’FL MARKET SEGMENTS ACCOUNTED FOR A SIGNIFICANT SHARE IN THE HUMAN MILK OLIGOSACCHARIDES MARKET54
FIGURE 26CANADA, THE US, MEXICO, AND CHINA EXPECTED TO GROW AT A SIGNIFICANT RATE DURING THE FORECAST PERIOD55

5MARKET OVERVIEW56
5.1INTRODUCTION56
5.2MACROECONOMIC INDICATORS56
5.2.1DIGITALIZATION OF THE RETAIL INDUSTRY56
FIGURE 27EU: ONLINE PURCHASES OF GOODS & SERVICES, 201857
5.2.2RISE IN THE NUMBER OF DUAL-INCOME HOUSEHOLDS57
FIGURE 28US: EMPLOYMENT STATUS OF PARENTS WITH CHILDREN
UNDER 18 YEARS, 202058
5.2.3RAPID URBANIZATION ACROSS REGIONS58
FIGURE 29URBAN AND RURAL POPULATIONS IN THE WORLD, 2016–202059
5.3MARKET DYNAMICS59
FIGURE 30MARKET DYNAMICS59
5.3.1DRIVERS60
5.3.1.1Rise in the infant population60
FIGURE 31GROWTH IN INFANT POPULATION, 2010–2020 (THOUSAND)60
5.3.1.2Growth in health awareness leading to increased consumption of dietary supplements60
FIGURE 32US: DIETARY CONSUMPTION RATE, BY AGE GROUP, 202061
5.3.1.3Extensive R&D initiatives by companies operating in the infant formula market61
5.3.2RESTRAINTS61
5.3.2.1Higher production costs associated with the development of HMO-composed supplements and food products61
5.3.2.2Stringent regulations and trade policies in the infant formula and dietary supplement industries62
5.3.3OPPORTUNITIES62
5.3.3.1Emergence of alternative animal milk oligosaccharides62
5.3.3.2Adoption of advanced technologies in the functional food industry62
5.3.4CHALLENGES63
5.3.4.1Complex industrial process to extract oligosaccharides from milk63
5.3.4.2Lack of consumer awareness regarding benefits associated with HMO-formulated products63
5.4KEY CONFERENCES & EVENTS63
TABLE 4HUMAN MILK OLIGOSACCHARIDES MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2022–202363
5.5KEY STAKEHOLDERS & BUYING CRITERIA64
5.5.1KEY STAKEHOLDERS IN THE BUYING PROCESS64
TABLE 5INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 MODES
OF APPLICATIONS64
5.5.2BUYING CRITERIA65
FIGURE 33INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS65
TABLE 6KEY BUYING CRITERIA FOR TOP 3 MODES OF APPLICATION65

6INDUSTRY TRENDS66
6.1OVERVIEW66
6.2REGULATORY FRAMEWORK66
6.3NORTH AMERICA66
6.3.1CANADA66
6.3.2US66
6.3.3MEXICO66
6.4EUROPEAN UNION (EU)67
6.5ASIA PACIFIC67
6.5.1JAPAN67
6.5.2CHINA67
6.5.3INDIA67
6.5.4AUSTRALIA & NEW ZEALAND68
6.6SOUTH AMERICA68
6.6.1BRAZIL68
6.6.2ARGENTINA68
6.7REST OF THE WORLD (ROW)69
6.7.1MIDDLE EAST69
6.8REGULATORY BODIES69
6.9PATENT ANALYSIS69
FIGURE 34HUMAN MILK OLIGOSACCHARIDES MARKET: PATENT ANALYSIS,
BY APPLICANT, 2017–202170
FIGURE 35HUMAN MILK OLIGOSACCHARIDES MARKET: PATENT ANALYSIS,
BY REGION, 2017–202170
FIGURE 36HUMAN MILK OLIGOSACCHARIDES MARKET: PATENT ANALYSIS,
BY LEGAL STATUS, 2017–202171
TABLE 7RECENT PATENTS GRANTED WITH RESPECT TO HMOS71
6.10VALUE CHAIN ANALYSIS72
FIGURE 37VALUE CHAIN ANALYSIS73
6.11COVID-19 IMPACT ON THE HUMAN MILK OLIGOSACCHARIDES MARKET73
6.12TREND/DISRUPTION IMPACTING BUYERS IN THE HUMAN MILK OLIGOSACCHARIDES MARKET73
FIGURE 38REVENUE SHIFT FOR THE HUMAN MILK OLIGOSACCHARIDES MARKET74
6.13MARKET ECOSYSTEM74
TABLE 8HUMAN MILK OLIGOSACCHARIDES MARKET: ECOSYSTEM74
6.14TECHNOLOGY ANALYSIS75
6.14.1HIGH-PERFORMANCE ANION-EXCHANGE CHROMATOGRAPHY FOR
HUMAN MILK OLIGOSACCHARIDES ANALYSIS75
6.14.2CAPILLARY ELECTROPHORESIS FOR HUMAN MILK OLIGOSACCHARIDES ANALYSIS76
6.15PORTER’S FIVE FORCES ANALYSIS76
TABLE 9PORTER’S FIVE FORCES ANALYSIS76
6.15.1INTENSITY OF COMPETITIVE RIVALRY76
6.15.2BARGAINING POWER OF SUPPLIERS77
6.15.3BARGAINING POWER OF BUYERS77
6.15.4THREAT OF SUBSTITUTES77
6.15.5THREAT OF NEW ENTRANTS77
6.16CASE STUDY ANALYSIS78
6.16.1USE CASE 1: LAYER ORIGIN INTRODUCED EASY-TO-USE AND EFFICIENT-TO-HMO PREBIOTIC PILLS AND POWDER FOR ADULTS78
6.17PRICE ANALYSIS78
6.17.1INTRODUCTION78
6.17.2PRICE ANALYSIS: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY TYPE, 2017-2021 (USD PER/KG)79
6.17.3PRICE ANALYSIS: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY REGION, 2017-2021 (USD PER/KG)79
7HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE80
7.1INTRODUCTION81
FIGURE 39HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION)81
TABLE 10HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2017–2021 (TONS)81
TABLE 11HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2022–2027 (TONS)82
TABLE 12HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)82
TABLE 13HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)82
7.1.1HUMAN MILK OLIGOSACCHARIDES MARKET: COVID-19 IMPACT ANALYSIS, BY TYPE83
TABLE 14REALISITIC SCENARIO: COVID-19 IMPACT ANALYSIS OF THE HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2017–2022 (USD MILLION)83
TABLE 15OPTIMISTIC SCENARIO: COVID-19 IMPACT ANALYSIS OF THE HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2017–2022 (USD MILLION)83
TABLE 16PESSIMISTIC SCENARIO: COVID-19 IMPACT ANALYSIS OF THE HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2017–2022 (USD MILLION)83
7.22’FL84
7.2.1AUTHORIZATION OF HMOS BY GOVERNMENT BODIES FOR CONSUMPTION84
TABLE 172’FL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2017–2021 (USD MILLION)84
TABLE 182’FL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2022–2027 (USD MILLION)85
TABLE 192’FL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2017–2021 (TONS)85
TABLE 202’FL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2022–2027 (TONS)86
7.33’FL86
7.3.1PREBIOTIC QUALITY OF 3’FL EXPECTED TO PROPEL THE GROWTH OF THE HUMAN MILK OLIGOSACCHARIDES MARKET IN THE UPCOMING YEARS86
TABLE 213’FL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2017–2021 (USD MILLION)86
TABLE 223’FL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2022–2027 (USD MILLION)87
TABLE 233’FL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2017–2021 (TONS)87
TABLE 243’FL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2022–2027 (TONS)88
7.43’SL88
7.4.1SIGNIFICANCE OF 3’SL IN LANGUAGE DEVELOPMENT DURING
EARLY CHILDHOOD88
TABLE 253’SL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2017–2021 (USD MILLION)88
TABLE 263’SL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2022–2027 (USD MILLION)89
TABLE 273’SL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2017–2021 (TONS)89
TABLE 283’SL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2022–2027 (TONS)90
7.56’SL90
7.5.1WIDE USAGE OF HMOS ACROSS INDUSTRIES90
TABLE 296’SL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2017–2021 (USD MILLION)91
TABLE 306’SL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2022–2027 (USD MILLION)91
TABLE 316’SL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2017–2021 (TONS)91
TABLE 326’SL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2022–2027 (TONS)92
8HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION93
8.1INTRODUCTION94
FIGURE 40HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION)94
TABLE 33HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION,
2017–2021 (USD MILLION)94
TABLE 34HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION,
2022–2027 (USD MILLION)95
8.1.1EXTENSIVE R&D ACTIVITIES BY INFANT FORMULA MANUFACTURERS95
TABLE 35INFANT FORMULA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION, 2017–2021 (USD MILLION)96
TABLE 36INFANT FORMULA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION, 2022–2027 (USD MILLION)96
8.2FUNCTIONAL FOOD & BEVERAGES97
8.2.1ROLE OF FAST-PACED LIFESTYLE AND GROWING ADOPTION OF CONVENIENCE FOOD PRODUCTS IN THE GROWTH OF FUNCTIONAL
FOOD & BEVERAGES97
TABLE 37FUNCTIONAL FOOD & BEVERAGES: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION, 2017–2021 (USD MILLION)97
TABLE 38FUNCTIONAL FOOD & BEVERAGES: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION, 2022–2027 (USD MILLION)98
8.3FOOD SUPPLEMENTS98
8.3.1GROWING HEALTH AWARENESS AND DEMAND FOR NUTRITION-RICH
FOOD PRODUCTS98
TABLE 39FOOD SUPPLEMENTS: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY REGION, 2017–2021 (USD MILLION)99
TABLE 40FOOD SUPPLEMENTS: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY REGION, 2022–2027 (USD MILLION)99
8.4OTHER APPLICATIONS100
8.4.1WIDE USAGE OF HMOS ACROSS INDUSTRIES100
TABLE 41OTHER APPLICATIONS: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY REGION, 2017–2021 (USD MILLION)100
TABLE 42OTHER APPLICATIONS: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY REGION, 2022–2027 (USD MILLION)100
9HUMAN MILK OLIGOSACCHARIDES MARKET, BY CONCENTRATION101
9.1INTRODUCTION102
FIGURE 41HUMAN MILK OLIGOSACCHARIDES MARKET, BY CONCENTRATION,
2022 VS. 2027 (USD MILLION)102
TABLE 43HUMAN MILK OLIGOSACCHARIDES MARKET, BY CONCENTRATION,
2017–2021 (USD MILLION)102
TABLE 44HUMAN MILK OLIGOSACCHARIDES MARKET, BY CONCENTRATION,
2022–2027 (USD MILLION)102
9.2NEUTRAL103
9.2.1RISING CONSUMER CONCERNS REGARDING GUT HEALTH AND IMMUNITY
IN INFANTS103
TABLE 45NEUTRAL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2017–2021 (USD MILLION)103
TABLE 46NEUTRAL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2022–2027 (USD MILLION)104
9.3ACIDIC104
9.3.1IMITATION OF HUMAN MILK IN PREMIUM INFANT FORMULAS104
TABLE 47ACIDIC: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2017–2021 (USD MILLION)105
TABLE 48ACIDIC: HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2022–2027 (USD MILLION)105
10HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION106
10.1INTRODUCTION107
FIGURE 42CHINA EXPECTED TO ACCOUNT FOR THE LARGEST SHARE IN THE HUMAN MILK OLIGOSACCHARIDES MARKET IN 2022108
FIGURE 43HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2022 VS. 2027 (USD MILLION)108
TABLE 49GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2017–2021 (USD MILLION)109
TABLE 50GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2022–2027 (USD MILLION)109
TABLE 51GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2017–2021 (TONS)109
TABLE 52GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION,
2022–2027 (TONS)110
TABLE 53GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)110
TABLE 54GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)110
TABLE 55GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (TONS)111
TABLE 56GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (TONS)111
TABLE 57GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2017–2021 (USD MILLION)111
TABLE 58GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2022–2027 (USD MILLION)112
TABLE 59GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY CONCENTRATION, 2017–2021(USD MILLION)112
TABLE 60GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY CONCENTRATION, 2022–2027 (USD MILLION)112
10.2HUMAN MILK OLIGOSACCHARIDES MARKET: COVID-19 IMPACT ANALYSIS - BY REGION113
TABLE 61REALISITIC SCENARIO: COVID-19 IMPACT ANALYSIS OF THE HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION, 2017–2022 (USD MILLION)113
TABLE 62OPTIMISTIC SCENARIO: COVID-19 IMPACT ANALYSIS OF THE HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION, 2017–2022 (USD MILLION)113
TABLE 63PESSIMISTIC SCENARIO: COVID-19 IMPACT ANALYSIS OF THE HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION, 2017–2022 (USD MILLION)113
10.3NORTH AMERICA114
FIGURE 44NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET SNAPSHOT, 2022115
TABLE 64NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY COUNTRY, 2017–2021 (USD MILLION)115
TABLE 65NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY COUNTRY, 2022–2027 (USD MILLION)116
TABLE 66NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2017–2021 (USD MILLION)116
TABLE 67NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2022–2027 (USD MILLION)116
TABLE 68NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2017–2021 (TONS)117
TABLE 69NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2022–2027 (TONS)117
TABLE 70NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY APPLICATION, 2017–2021 (USD MILLION)117
TABLE 71NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY APPLICATION, 2022–2027 (USD MILLION)118
TABLE 72NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY CONCENTRATION, 2017–2021 (USD MILLION)118
TABLE 73NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY CONCENTRATION, 2022–2027 (USD MILLION)118
10.3.1US119
10.3.1.1Increased demand from end-user companies, such as Nestlé S.A. (Switzerland) and Danone S.A. (France)119
TABLE 74US: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)119
TABLE 75US: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)119
10.3.2CANADA120
10.3.2.1Cronobacter Sakazakii or Salmonella Newport infection among infants hindering the Canadian human milk oligosaccharides market120
TABLE 76CANADA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)120
TABLE 77CANADA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)120
10.3.3MEXICO121
10.3.3.1Rise in per capita expenditure on nutritious and healthy foods estimated to boost the market121
TABLE 78MEXICO: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)121
TABLE 79MEXICO: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)121
10.4EUROPE122
TABLE 80EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY COUNTRY,
2017–2021 (USD MILLION)122
TABLE 81EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY COUNTRY,
2022–2027 (USD MILLION)123
TABLE 82EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)123
TABLE 83EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)123
TABLE 84EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (TONS)124
TABLE 85EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (TONS)124
TABLE 86EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2017–2021 (USD MILLION)124
TABLE 87EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2022–2027 (USD MILLION)125
TABLE 88EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY CONCENTRATION, 2017–2021 (USD MILLION)125
TABLE 89EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY CONCENTRATION, 2022–2027 (USD MILLION)125
10.4.1GERMANY126
10.4.1.1Continuous research and development in the HMO segment126
TABLE 90GERMANY: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)126
TABLE 91GERMANY: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)126
10.4.2UK127
10.4.2.1Introduction of HMO-based infant formulas127
TABLE 92UK: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)127
TABLE 93UK: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)127
10.4.3FRANCE128
10.4.3.1Strategic initiatives taken by local players128
TABLE 94FRANCE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)128
TABLE 95FRANCE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)128
10.4.4SPAIN129
10.4.4.1Consumer preference for clean-label ingredients paving the way for 2’FL dietary supplement products129
TABLE 96SPAIN: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)129
TABLE 97SPAIN: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)129
10.4.5ITALY130
10.4.5.1Increasing popularity of HMO-based adult supplements130
TABLE 98ITALY: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)130
TABLE 99ITALY: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)130
10.4.6REST OF EUROPE131
10.4.6.1Aggressive marketing around infant formulas and misleading health claims hindering human milk oligosaccharides market growth131
TABLE 100REST OF EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2017–2021 (USD MILLION)131
TABLE 101REST OF EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2022–2027 (USD MILLION)131
10.5ASIA PACIFIC132
FIGURE 45ASIA PACIFIC: HUMAN MILK OLIGOSACCHARIDES MARKET SNAPSHOT, 2022133
TABLE 102ASIA PACIFIC: HUMAN MILK OLIGOSACCHARIDES MARKET, BY COUNTRY, 2017–2021 (USD MILLION)134
TABLE 103ASIA PACIFIC: HUMAN MILK OLIGOSACCHARIDES MARKET, BY COUNTRY, 2022–2027 (USD MILLION)134
TABLE 104ASIA PACIFIC: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)134
TABLE 105ASIA PACIFIC: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)135
TABLE 106ASIA PACIFIC: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (TONS)135
TABLE 107ASIA PACIFIC: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (TONS)135
TABLE 108ASIA PACIFIC: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2017–2021 (USD MILLION)136
TABLE 109ASIA PACIFIC: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2022–2027 (USD MILLION)136
TABLE 110ASIA PACIFIC: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY CONCENTRATION, 2017–2021 (USD MILLION)136
TABLE 111ASIA PACIFIC: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY CONCENTRATION, 2022–2027 (USD MILLION)137
10.5.1CHINA137
10.5.1.1Continuous research & development in the field of HMO expected to expand the market137
TABLE 112CHINA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)137
TABLE 113CHINA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)138
10.5.2INDIA138
10.5.2.1Millennial population playing an important role in driving the demand for HMO-based food products138
TABLE 114INDIA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)139
TABLE 115INDIA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)139
10.5.3JAPAN139
10.5.3.1Stringent rules and regulations by the Japanese government bodies challenging human milk oligosaccharides market growth139
TABLE 116JAPAN: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)140
TABLE 117JAPAN: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)140
10.5.4AUSTRALIA & NEW ZEALAND141
10.5.4.1Approval for the use of 2’FL HMOs in infant formula141
TABLE 118AUSTRALIA & NEW ZEALAND: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2017–2021 (USD MILLION)141
TABLE 119AUSTRALIA & NEW ZEALAND: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2022–2027 (USD MILLION)141
10.5.5REST OF ASIA PACIFIC142
10.5.5.1Strategic decisions undertaken142
TABLE 120REST OF ASIA PACIFIC: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2017–2021 (USD MILLION)142
TABLE 121REST OF ASIA PACIFIC: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2022–2027 (USD MILLION)142
10.6SOUTH AMERICA143
TABLE 122SOUTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY COUNTRY, 2017–2021 (USD MILLION)143
TABLE 123SOUTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY COUNTRY, 2022–2027 (USD MILLION)143
TABLE 124SOUTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2017–2021 (USD MILLION)144
TABLE 125SOUTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2022–2027 (USD MILLION)144
TABLE 126SOUTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2017–2021 (TONS)144
TABLE 127SOUTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2022–2027 (TONS)145
TABLE 128SOUTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY APPLICATION, 2017–2021 (USD MILLION)145
TABLE 129SOUTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY APPLICATION, 2022–2027 (USD MILLION)145
TABLE 130SOUTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY CONCENTRATION, 2017–2021 (USD MILLION)146
TABLE 131SOUTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY CONCENTRATION, 2022–2027 (USD MILLION)146
10.6.1BRAZIL146
10.6.1.1Infant formulas gaining popularity due to their ease of use146
TABLE 132BRAZIL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)147
TABLE 133BRAZIL: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)147
10.6.2ARGENTINA147
10.6.2.1Growing inclination toward functional food147
TABLE 134ARGENTINA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)148
TABLE 135ARGENTINA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)148
10.6.3REST OF SOUTH AMERICA148
10.6.3.1Influence of health and wellness trends148
TABLE 136REST OF SOUTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY TYPE, 2017–2021 (USD MILLION)149
TABLE 137REST OF SOUTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET,
BY TYPE, 2022–2027 (USD MILLION)149
10.7REST OF THE WORLD (ROW)149
TABLE 138ROW: HUMAN MILK OLIGOSACCHARIDES MARKET, BY COUNTRY,
2017–2021 (USD MILLION)150
TABLE 139ROW: HUMAN MILK OLIGOSACCHARIDES MARKET, BY COUNTRY,
2022–2027 (USD MILLION)150
TABLE 140ROW: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)150
TABLE 141ROW: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)151
TABLE 142ROW: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (TONS)151
TABLE 143ROW: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (TONS)151
TABLE 144ROW: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION,
2017–2021 (USD MILLION)152
TABLE 145ROW: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION,
2022–2027 (USD MILLION)152
TABLE 146ROW: HUMAN MILK OLIGOSACCHARIDES MARKET, BY CONCENTRATION, 2017–2021 (USD MILLION)152
TABLE 147ROW: HUMAN MILK OLIGOSACCHARIDES MARKET, BY CONCENTRATION, 2022–2027 (USD MILLION)153
10.7.1MIDDLE EAST153
10.7.1.1Complementary food feeding among infants153
TABLE 148MIDDLE EAST: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)153
TABLE 149MIDDLE EAST: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)154
10.7.2AFRICA154
10.7.2.1Prevalence of vitamin deficiency among women and children154
TABLE 150AFRICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2017–2021 (USD MILLION)154
TABLE 151AFRICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE,
2022–2027 (USD MILLION)155
11COMPETITIVE LANDSCAPE156
11.1OVERVIEW156
11.2MARKET SHARE ANALYSIS, 2021156
TABLE 152HUMAN MILK OLIGOSACCHARIDES MARKET: DEGREE OF COMPETITION156
11.3KEY PLAYER STRATEGIES157
11.4HISTORICAL REVENUE ANALYSIS OF KEY PLAYERS158
FIGURE 46THREE-YEAR TOTAL REVENUE ANALYSIS OF KEY PLAYERS IN THE MARKET, 2019–2021 (USD BILLION)158
11.5COVID-19-SPECIFIC COMPANY RESPONSE159
11.5.1DSM159
11.5.2BASF SE159
11.5.3DUPONT159
11.5.4CHR HANSEN HOLDING A/S159
11.6COMPANY EVALUATION QUADRANT (KEY PLAYERS)160
11.6.1STARS160
11.6.2EMERGING LEADERS160
11.6.3PERVASIVE PLAYERS160
11.6.4PARTICIPANTS160
FIGURE 47HUMAN MILK OLIGOSACCHARIDES MARKET: COMPANY EVALUATION QUADRANT, 2021 (KEY PLAYERS)161
11.7PRODUCT FOOTPRINT162
TABLE 153COMPANY, BY TYPE FOOTPRINT162
TABLE 154COMPANY, BY APPLICATION FOOTPRINT163
TABLE 155COMPANY, BY REGIONAL FOOTPRINT164
TABLE 156COMPANY, BY OVERALL FOOTPRINT165

11.8START-UP/SME EVALUATION QUADRANT (OTHER PLAYERS)165
11.8.1PROGRESSIVE COMPANIES165
11.8.2STARTING BLOCKS165
11.8.3RESPONSIVE COMPANIES166
11.8.4DYNAMIC COMPANIES166
TABLE 157DETAILED LIST OF KEY STARTUP/SMES166
TABLE 158HUMAN MILK OLIGOSACCHARIDES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES167
FIGURE 48HUMAN MILK OLIGOSACCHARIDES MARKET: COMPANY EVALUATION QUADRANT, 2021 (OTHER PLAYERS)168
11.9COMPETITIVE SCENARIO169
11.9.1NEW PRODUCT LAUNCHES169
TABLE 159HUMAN MILK OLIGOSACCHARIDES MARKET: NEW PRODUCT LAUNCHES, 2018–2021169
11.9.2DEALS170
TABLE 160HUMAN MILK OLIGOSACCHARIDES MARKET: DEALS, 2018–2021170
12COMPANY PROFILES172
12.1KEY PLAYERS172
(Business overview, Products offered, Recent Developments, MNM view)*
12.1.1DSM172
TABLE 161DSM: BUSINESS OVERVIEW172
FIGURE 49DSM: COMPANY SNAPSHOT173
TABLE 162DSM: PRODUCTS OFFERED173
TABLE 163DSM: DEALS174
12.1.2BASF SE.175
TABLE 164BASF SE.: BUSINESS OVERVIEW175
FIGURE 50BASF SE.: COMPANY SNAPSHOT176
TABLE 165BASF SE.: PRODUCTS OFFERED176
TABLE 166BASF SE: NEW PRODUCT LAUNCHES177
TABLE 167BASF SE.: DEALS177
12.1.3CHR HANSENHOLDING A/S178
TABLE 168CHR HANSEN HOLDING A/S: BUSINESS OVERVIEW178
FIGURE 51CHR. HANSEN HOLDINGS A/S: COMPANY SNAPSHOT179
TABLE 169CHR. HANSEN HOLDINGS A/S: PRODUCTS OFFERED179
TABLE 170CHR. HANSEN HOLDING A/S: DEALS180
12.1.4DUPONT181
TABLE 171DUPONT: BUSINESS OVERVIEW181
FIGURE 52DUPONT: COMPANY SNAPSHOT182
TABLE 172DUPONT: PRODUCTS OFFERED182
TABLE 173DUPONT: NEW PRODUCT LAUNCHES183
TABLE 174DUPONT: DEALS183
12.1.5NESTLE185
TABLE 175NESTLE: BUSINESS OVERVIEW185
FIGURE 53NESTLE: COMPANY SNAPSHOT186
TABLE 176NESTLE: PRODUCTS OFFERED186
TABLE 177NESTLE: NEW PRODUCT LAUNCHES187
12.1.6BIOSYNTH CARBOSYNTH188
TABLE 178BIOSYNTH CARBOSYNTH: BUSINESS OVERVIEW188
TABLE 179BIOSYNTH CARBOSYNTH: PRODUCTS OFFERED188
TABLE 180BIOSYNTH CARBOSYNTH: DEALS189
12.1.7INBIOSE NV.190
TABLE 181INBIOSE NV.: BUSINESS OVERVIEW190
TABLE 182INBIOSE NV: PRODUCTS OFFERED190
12.1.8GNUBIOTICS SCIENCES S.A.192
TABLE 183GNUBIOTICS SCIENCES S.A.: BUSINESS OVERVIEW192
TABLE 184GNUBIOTICS SCIENCES S.A.: PRODUCTS OFFERED192
TABLE 185GNUBIOTICS SCIENCES S.A.: NEW PRODUCT LAUNCHES193
12.1.9ABBOTT LABORATORIES194
TABLE 186ABBOTT LABORATORIES: BUSINESS OVERVIEW194
FIGURE 54ABBOTT LABORATORIES: COMPANY SNAPSHOT194
TABLE 187ABBOTT LABORATORIES: PRODUCTS OFFERED195
TABLE 188ABBOTT LABORATORIES: NEW PRODUCT LAUNCHES195
12.1.10ROYAL FRIESLANDCAMPINA N.V196
TABLE 189ROYAL FRIESLANDCAMPINA N.V: BUSINESS OVERVIEW196
FIGURE 55ROYAL FRIESLANDCAMPINA N.V: COMPANY SNAPSHOT197
TABLE 190ROYAL FRIESLANDCAMPINA N.V: PRODUCTS OFFERED197
TABLE 191ROYAL FRIESLANDCAMPINA N.V: NEW PRODUCT LAUNCHES198
TABLE 192ROYAL FRIESLANDCAMPINA N.V: DEALS198
12.1.11ELICITYL S.A199
TABLE 193ELICITYL S.A.: BUSINESS OVERVIEW199
TABLE 194ELICITYL S.A: PRODUCTS OFFERED199
12.1.12DEXTRA LABORATORIES LTD.201
TABLE 195DEXTRA LABORATORIES LTD.: BUSINESS OVERVIEW201
TABLE 196DEXTRA LABORATORIES LTD.: PRODUCTS OFFERED201
12.2START-UPS/SME’S/OTHER PLAYERS202
12.2.1ZUCHEM INC.202
TABLE 197ZUCHEM INC.: COMPANY OVERVIEW202
12.2.2ADVANCED PROTEIN TECHNOLOGIES CORP.203
TABLE 198ADVANCED PROTEIN TECHNOLOGIES CORP.: COMPANY OVERVIEW203
12.2.3CONAGEN INC.203
TABLE 199CONAGEN INC.: COMPANY OVERVIEW203
12.2.4KYOWA HAKKO BIO CO. LTD.204
TABLE 200KYOWA HAKKA BIO CO. LTD.: COMPANY OVERVIEW204
12.2.5MEDOLAC LABORATORIES204
TABLE 201MEDOLAC LABORATORIES: COMPANY OVERVIEW204
12.3END USER COMPANY PROFILES205
12.3.1H & H GROUP205
TABLE 202H&H GROUP: BUSINESS OVERVIEW205
TABLE 203H&H GROUP: PRODUCTS OFFERED205
12.3.2LAYER ORIGIN NUTRITION206
TABLE 204LAYER ORIGIN NUTRITION: BUSINESS OVERVIEW206
TABLE 205LAYER ORIGIN NUTRITION: PRODUCTS OFFERED206
12.3.3STANDARD PROCESS INC.207
TABLE 206STANDARD PROCESS INC.: BUSINESS OVERVIEW207
TABLE 207STANDARD PROCESS INC.: PRODUCTS OFFERED207
12.3.4RECKITT BENCKISER GROUP208
TABLE 208RECKITT BENCKISER GROUP: BUSINESS OVERVIEW208
TABLE 209RECKITT BENCKISER GROUP: PRODUCTS OFFERED208
12.3.5AMAZON209
TABLE 210AMAZON: BUSINESS OVERVIEW209
TABLE 211AMAZON: PRODUCTS OFFERED209
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
13ADJACENT & RELATED MARKETS210
13.1INTRODUCTION210
13.2INFANT FORMULA INGREDIENTS MARKET210
13.2.1LIMITATIONS210
13.2.2MARKET DEFINITION210
13.2.3MARKET OVERVIEW211
13.2.4INFANT FORMULA INGREDIENTS MARKET, BY I

Report Title: HMO Market by Type (2’ Fl, 3’ Fl, 3’ Sl, 6’ Sl), Application (Infant Formula, Functional Food & Beverages, Food Supplement), Concentration (Acidic, Neutral) & Region (North America, Europe, APAC, South America, RoW) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Drip Irrigation Market by Crop Type, Component (Drip Mainlines/Drip Tubes, Filters & Fertilizer Injectors, Fittings & Accessories, Emitters/Drippers, Pressure Pumps, and Valves), Emitter/Dripper Type, Application and Region - Global Forecast to 2027

Drip Irrigation Market by Crop Type, Component (Drip Mainlines/Drip Tubes, Filters & Fertilizer Injectors, Fittings & Accessories, Emitters/Drippers, Pressure Pumps, and Valves), Emitter/Dripper Type, Application and Region - Global Forecast to 2027

Plant Extracts Market by Product Type (Oleoresins, Essential Oils, Flavonoids, Alkaloids, Carotenoids), Application (Food & Beverages, Cosmetics, Pharmaceuticals, Dietary Supplements), Form, Source and Region - Global Forecast to 2027

Plant Extracts Market by Product Type (Oleoresins, Essential Oils, Flavonoids, Alkaloids, Carotenoids), Application (Food & Beverages, Cosmetics, Pharmaceuticals, Dietary Supplements), Form, Source and Region - Global Forecast to 2027

Pet Food Ingredients Market by Ingredient (Meat & Meat Products, Cereals, Vegetables & Fruits, Fats, and Additives), Source (Animal-based, Plant Derivatives, and Synthetic), Pet (Dogs, Cats, and Fish), Form and Region - Global Forecast to 2027

Pet Food Ingredients Market by Ingredient (Meat & Meat Products, Cereals, Vegetables & Fruits, Fats, and Additives), Source (Animal-based, Plant Derivatives, and Synthetic), Pet (Dogs, Cats, and Fish), Form and Region - Global Forecast to 2027

Cannabis Market by Product Type (Flowers, Concentrates, Edibles, Topicals & Tinctures), Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), Application (Medical and Recreational), and Region (North America, South America, Europe and RoW) - Global Forecast to 2027

Cannabis Market by Product Type (Flowers, Concentrates, Edibles, Topicals & Tinctures), Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), Application (Medical and Recreational), and Region (North America, South America, Europe and RoW) - Global Forecast to 2027

Cannabis Extraction: Global Markets

Cannabis Extraction: Global Markets

Biocontrol Market by Type (Biopesticides and Semiochemicals), Source (Microbials, Biochemicals, and Macrobials), Mode of Application, Crop Type, and Region (North America, Europe, APAC, South America, Rest of the World) - Global Forecast to 2027

Biocontrol Market by Type (Biopesticides and Semiochemicals), Source (Microbials, Biochemicals, and Macrobials), Mode of Application, Crop Type, and Region (North America, Europe, APAC, South America, Rest of the World) - Global Forecast to 2027